Breakthrough method gives ‘snapshot’ of a plant’s metabolic effects
Scientists developed a new way to help understand what happens in the body when people consume a plant…
Fake Mounjaro pens supplied through UK online pharmacy
C+D has been informing, supporting and championing community pharmacy since 1859 and is proud to be at the…
Has Australia’s social media ban worked? The eSafety Commissioner is monitoring kids’ Ritalin use to find out
February 26, 2026 — 12:01am Save You have reached your maximum number of saved items. Remove items from…
1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market Crash
Although pegged as a weight-loss stock, this drug maker’s core business has long been diabetes. Novo Nordisk (NVO…
Survivors of thalidomide drug to be offered formal State apology – The Irish Times
Survivors of the thalidomide drug scandal will be offered a formal State apology. A commitment to a State…
Move Free Chiropractic has opened a new clinic in Ely
What is the name of your business? Move Free Chiropractic What do you do? We offer chiropractic services,…
1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market Crash
Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs.…
Can GLP-1 Weight Loss Drugs Cause Scurvy? What to Know
Share on PinterestReports of people developing scurvy while taking GLP-1 medications are on the rise. Milles Team/ShutterstockReports of…
Portuguese people struggle the most to pay for medicines
The data is revealed in a study that estimates 1,577 preventable annual deaths with greater equity in access…
Migraine pills ‘restore patient’s life’ as thousands benefit from first-ever tablets
An NHS regulator highlighted the ‘rapid take-up’ of new migraine pills to stop a key protein which causes…
MHRA disrupts second manufacturing facility suspected to be involved in the manufacture of illegal weight loss medicines in latest blow to criminal network
Officers from the Criminal Enforcement Unit (CEU) of the Medicines and Healthcare products Regulatory Agency (MHRA) have raided two separate premises in…
FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia
FDA PDUFA Goal Date Set for October 17, 2026 PITTSBURGH, Feb. 25, 2026 /PRNewswire/ —Â Viatris Inc. (Nasdaq: VTRS),…